PAX7 and facioscapulohumeral muscular dystrophy: We have now evaluated our PAX7 target gene repression biomarker alongside the full Yao et al. (2014) (30) and our two DUX4 target gene expression biomarkers across nine independent FSHD transcriptomic data sets here and previously (28).